Answers are grounded in this paper and cite their sources.
Objective: Osteoarthritis (OA) of the knee and/or hip is a chronic degenerative disease that severely impacts quality of life. Current treatments, such as NSAIDs, provide only symptomatic relief and are associated with significant side effects. This study evaluates whether short-term supplementation with a glucosamine complex (glucosamine, chondroitin, hyaluronic acid, omega-3, type II collagen) can improve OA symptoms. Methods: A prospective observational study recruited 200 OA patients from family physician practices in Latvia. Patients were divided into 1) Study group (n = 100) receiving Artroveron® 5in1 COMPLEX WITH OMEGA-3 (Glucosamine hydrochloride 300 mg, Omega-3 fatty acids 100 mg, Chondroitin sulfate 50 mg, Hyaluronic acid 20 mg, Type II collagen 20 mg); 2) Control group (n = 100) receiving no chondroprotectors. Pain levels were assessed at baseline and after 30 days using: Western Ontario and McMaster Universities Arthritis Index (WOMAC), Visual Analogue Scale (VAS). Results: Study group (glucosamine complex) had a statistically significant reduction in pain scores compared to the control group (p < 0.001). WOMAC pain score decreased from 7.3 ± 3.8 to 6.0 ± 3.6 (p < 0.001). WOMAC stiffness score improved from 3.4 ± 1.7 to 2.6 ± 1.8 (p < 0.001). WOMAC difficulty score reduced from 26.6 ± 11.3 to 21.0 ± 11.5 (p < 0.001). VAS pain score decreased from 5.8 ± 1.6 to 4.9 ± 1.5 in the study group, compared to 4.8 ± 1.8 to 4.2 ± 2.0 in controls (p < 0.001). Conclusion: Short-term supplementation with Artroveron® 5in1 COMPLEX WITH OMEGA-3 significantly reduced OA pain and stiffness compared to untreated control group. These findings suggest that glucosamine supplementation may serve as an effective alternative for OA symptom management.
No takes yet. Share an insight, caveat, or question.
Puce et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: